Sleep Apnea Implants Market Size, Share & Trends Analysis Report By Product Type (Hypoglossal Neurostimulation Devices, Phrenic Nerve Stimulator, Palatal Implants), By Indication (Obstructive Sleep Apnea, Central Sleep Apnea), By End User (Hospitals, Ambulatory Surgical Centers, Others), Global Economy Insights, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023 - 2031
Market Overview:
The Sleep apnea implants market size was USD 320.3 million in 2022. Covid-19's impacts have been unprecedented and staggering on a global scale, with the pandemic leading to positive demand shocks for the Sleep apnea implants market across all domains and regions. Between 2023 and 2031, the market is projected to grow at a CAGR of 15.5%, from USD 325.8 million in 2023 to USD 1.30 billion in 2031. The sudden rise in CAGR is attributed to this market growth returning to the pre-pandemic level once the pandemic is over.
Sleep apnea is a sleep disorder characterized by breathing interruptions during sleep, which can result in poor sleep quality and various health problems. Sleep apnea implants are small medical devices that are surgically implanted in the upper airway to help keep it open during sleep and prevent breathing interruptions.
The sleep apnea implants market includes the sales of these devices and related services such as implantation surgeries, maintenance, and replacements. The market scope includes various types of implants such as hypoglossal nerve stimulation (HNS) implants, tongue stabilization implants, and palatal implants.
The market is driven by the increasing prevalence of sleep apnea, the growing demand for minimally invasive surgical procedures, and advancements in implant technology. The market is also expected to be driven by the rising awareness about sleep apnea and its associated health risks, as well as the increasing adoption of sleep apnea treatments in emerging economies.
Scope of Sleep Apnea Implants Market Report:
A recent market research report added to repository of Intellectual Market Insights Research is an in-depth analysis of Global Sleep Apnea Implants Market. On the basis of historic growth analysis and current scenario of Sleep Apnea Implants market place, the report intends to offer actionable insights on global market growth projections. Authenticated data presented in report is based on findings of extensive primary and secondary research. Insights drawn from data serve as excellent tools that facilitate deeper understanding of multiple aspects of global Sleep Apnea Implants market. This further helps users with their developmental strategy.
This report examines all the key factors influencing growth of global Sleep Apnea Implants market, including demand-supply scenario, pricing structure, profit margins, production and value chain analysis. Regional assessment of global Sleep Apnea Implants market unlocks a plethora of untapped opportunities in regional and domestic market places. Detailed company profiling enables users to evaluate company shares analysis, emerging product lines, pricing strategies, innovation possibilities and much more.
The report covers the all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers.
Market Drivers:
According to a report by the World Health Organization (WHO), an estimated 1 billion people worldwide suffer from sleep apnea, with moderate to severe cases affecting approximately 100 million people globally. The report also states that the prevalence of sleep apnea is expected to increase due to rising obesity rates and aging populations.
News reports also highlight the increasing prevalence of sleep apnea and the growing demand for treatment options. For example, an article in the Wall Street Journal reported that sleep apnea is a growing health problem in the United States, with an estimated 22 million Americans suffering from the disorder.
The article notes that the demand for sleep apnea treatments, including implants, is increasing due to greater awareness of the disorder and its associated health risks. Additionally, a report by Medical Device Network noted that the demand for sleep apnea implants is increasing in Europe, particularly in countries such as Germany, France, and the UK, due to the high prevalence of sleep apnea and the growing adoption of implantable devices as a treatment option.
For example, some manufacturers are developing sleep apnea implants with real-time monitoring and adjustment capabilities, which can improve the effectiveness of the devices and reduce the need for manual adjustments. Other companies are exploring the use of artificial intelligence (AI) and machine learning algorithms to optimize implant settings and improve patient outcomes.
This trend is supported by research and development activities in the field. For example, a study published in the Journal of Clinical Sleep Medicine evaluated the efficacy and safety of a new implantable device for treating sleep apnea. The device, called the aura6000, is designed to stimulate the genioglossus muscle in the tongue to maintain airway patency during sleep. The study found that the aura6000 was effective in reducing the severity of sleep apnea and improving sleep quality in patients.
News reports also highlight the trend of developing advanced implantable devices for sleep apnea treatment. For example, an article in MD+DI (Medical Device and Diagnostic Industry) notes that several companies are investing in research and development activities to develop new implantable devices for sleep apnea treatment, with a focus on improving patient outcomes and reducing the need for manual adjustments. The article also notes that the sleep apnea implants market is expected to grow as these advanced devices become more widely available and affordable.
Market Restraining Factors:
According to the research the average cost of a sleep apnea implant ranges from USD 20,000 to USD 30,000, which may make it unaffordable for some patients, particularly in developing countries with limited healthcare resources.
Furthermore, the lack of insurance coverage and reimbursement policies for sleep apnea implant procedures in some countries may further limit their adoption. A study published in the Journal of Clinical Sleep Medicine found that insurance coverage for sleep apnea implants varies widely across countries, with some countries providing no coverage at all. This can result in limited access to these devices for patients who may benefit from them.
These factors may impact the growth of the sleep apnea implants market, as patients may opt for other, more affordable treatment options such as continuous positive airway pressure (CPAP) devices or oral appliances.
News reports also highlight the high cost of sleep apnea implants as a potential barrier to their adoption. For example, an article in Becker's Hospital Review notes that the high cost of sleep apnea implants is a challenge for healthcare providers and patients, particularly in the United States where insurance coverage and reimbursement policies vary widely. The article also notes that some healthcare providers are exploring alternative payment models to make these devices more affordable for patients.
Key Players Strategies in the Market:
List of Companies Profiled:
Key Industry Developments:
Sleep Apnea Implants Market Segmentation Analysis:
The market scope is segmented on the basis by product type, by indication, by end user, by region
Hypoglossal Neurostimulation Devices: These are medical devices that are designed to treat obstructive sleep apnea by stimulating the hypoglossal nerve, which controls the muscles of the tongue and throat. The device is implanted under the skin in the chest and includes a small electrode that is placed on the hypoglossal nerve. When the device is activated during sleep, it stimulates the nerve and helps to keep the airway open.
Phrenic Nerve Stimulator: This is a medical device that is designed to help patients with spinal cord injuries or other conditions that cause paralysis to breathe. The device is implanted under the skin in the chest and includes electrodes that are placed on the phrenic nerve, which controls the diaphragm muscle. When the device is activated, it stimulates the nerve and causes the diaphragm to contract, allowing the patient to breathe.
Others: This category likely includes a variety of other medical devices that are not specifically hypoglossal neurostimulation devices or phrenic nerve stimulators. It's possible that this category includes devices such as implantable cardiac devices, cochlear implants, or other types of neurostimulation devices. The specific devices included in this category would depend on the market being studied.
Obstructive Sleep Apnea: This is a sleep disorder that is characterized by episodes of partial or complete blockage of the upper airway during sleep. It can cause loud snoring, disrupted sleep, and daytime fatigue, and it is often treated with continuous positive airway pressure (CPAP) therapy. Hypoglossal neurostimulation devices may be used as an alternative treatment option for patients who are unable to tolerate or benefit from CPAP therapy.
Central Sleep Apnea: This is a sleep disorder in which breathing repeatedly stops and starts during sleep due to a lack of respiratory effort. Unlike obstructive sleep apnea, which is caused by a physical blockage of the airway, central sleep apnea is caused by a problem with the brain's control of breathing. Phrenic nerve stimulators may be used to treat central sleep apnea by stimulating the phrenic nerve, which controls the diaphragm, to improve breathing during sleep.
Hospitals: Hospitals are healthcare facilities that provide a wide range of medical services, including inpatient and outpatient care, emergency services, and surgical procedures. Hospitals are often major purchasers of medical devices, including hypoglossal neurostimulation devices, phrenic nerve stimulators, and other respiratory devices.
Ambulatory Surgical Centers: Ambulatory surgical centers (ASCs) are facilities that provide outpatient surgical procedures, including diagnostic and therapeutic procedures. ASCs are often smaller than hospitals and may specialize in certain types of procedures. They may also be more cost-effective than hospitals for certain procedures. ASCs may use medical devices such as hypoglossal neurostimulation devices and phrenic nerve stimulators to treat sleep-disordered breathing.
Others: The "Others" category may include a variety of other end users, such as home healthcare providers, sleep clinics, and rehabilitation centers. These end users may also purchase and use medical devices such as hypoglossal neurostimulation devices, phrenic nerve stimulators, and other respiratory devices to treat patients with sleep-disordered breathing and other respiratory conditions.
Regional Analysis:
North America: The North America region is the largest market for sleep apnea implants, due to the high prevalence of sleep apnea and the presence of key players in the region. In the US, the FDA has approved several implantable devices for sleep apnea treatment, including the Inspire hypoglossal nerve stimulation device and the Provent nasal device. In January 2021, Inspire Medical Systems received FDA approval for its new Inspire 2.0 device, which is designed to provide real-time monitoring and automatic adjustments. In March 2021, Respicardia announced that it had received FDA approval for its remedē implantable device for sleep apnea treatment.
Europe: The Europe region is expected to witness significant growth in the sleep apnea implants market, due to increasing awareness of sleep apnea and rising demand for minimally invasive treatment options. Key players in the region include LivaNova, Nyxoah, and ImThera Medical. In September 2020, Nyxoah announced that it had received CE Mark approval for its Genio system, a hypoglossal nerve stimulation device for sleep apnea treatment.
Asia Pacific: The Asia Pacific region is expected to witness significant growth in the sleep apnea implants market, due to the increasing prevalence of sleep apnea and rising demand for advanced treatment options. Key players in the region include BMC Medical, Airing, and Zephyr Sleep Technologies. In September 2020, BMC Medical announced that it had received China Food and Drug Administration approval for its implantable hypoglossal nerve stimulation device for sleep apnea treatment.
Latin America: The Latin America region is expected to witness moderate growth in the sleep apnea implants market, due to the increasing prevalence of sleep apnea and rising demand for advanced treatment options. Key players in the region include Inspire Medical Systems and Respicardia. In October 2020, Inspire Medical Systems announced that it had received regulatory approval in Brazil for its Inspire hypoglossal nerve stimulation device.
Middle East & Africa: The Middle East & Africa region is expected to witness moderate growth in the sleep apnea implants market, due to the increasing prevalence of sleep apnea and rising demand for advanced treatment options. Key players in the region include ImThera Medical and Respicardia. In November 2020, ImThera Medical announced that it had received regulatory approval in Israel for its aura6000 implantable device for sleep apnea treatment
Global Sleep Apnea Implants Market Regional Analysis:
North America accounted for the highest xx% market share in terms of revenue in the Sleep Apnea Implants market and is expected to expand at a CAGR of xx% during the forecast period. This growth can be attributed to the growing adoption of Sleep Apnea Implants. The market in APAC is expected to witness significant growth and is expected to register a CAGR of xx% over upcoming years, because of the presence of key Sleep Apnea Implants companies in economies such as Japan and China.
The objective of the report is to present comprehensive analysis of Global Sleep Apnea Implants Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language.
Sleep Apnea Implants Market Report is also available for below Regions and Country Please Ask for that
Report Coverage:
The report will cover the qualitative and quantitative data on the global sleep apnea implants market. The qualitative data includes latest trends, market players analysis, market drivers, market opportunity, and many others. Also, the report quantitative data includes market size for every region, country and segments according to your requirements. We can also provide customize report in every industry vertical.
Report Scope and Segmentations:
Study Period | 2020-31 |
Base Year | 2022 |
Estimated Forecast Year | 2023-31 |
Growth Rate | CAGR of 15.5% from 2023 to 2031 |
Segmentation | By product type, By Indication, By end user, By region. |
Unit | USD Billion |
By product type |
|
By Indication |
|
By end user |
|
By region |
|
Points Covered in the Report:
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analysed 5 years data history and forecast.
The growth factors of the market are discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc., and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Questions:
Research Scope of Sleep Apnea Implants Market:
Sleep Apnea Implants Market Trends: Market key trends which include Increased Competition and Continuous Innovations Trends:
Frequently Asked Questions
The global Sleep apnea implants market was valued at USD 320.3 million in 2022. The market is expected to grow at a compound annual growth rate (CAGR) of 15.5% from 2023 to 2031, reaching a value of USD 1.30 billion by 2031.
North America had the largest share of the global sleep apnea implants market in 2021, followed by Europe and the Asia Pacific region.
The driving factors for the sleep apnea implants market include increasing prevalence of sleep apnea, rising awareness about treatment options, and technological advancements in sleep apnea implants.
The implantable neurostimulators segment is expected to be the leading segment in the global sleep apnea implants market during the forecast period.
Some of the major players in the sleep apnea implants market include Inspire Medical Systems, Inc., LivaNova PLC, ResMed, Inc., and Medtronic plc, among others.
Want to Review Complete Market Research Report
Customize this Report
Related Reports